01 4Orion Corporation
02 4APOTEX INC
03 4BGP PHARMA ULC
04 3Natco Pharma Limited
05 3PRO DOC LIMITEE
06 2TEVA CANADA LIMITED
01 13ALPRAZOLAM
02 7Alprazolam
01 17TABLET
02 3Tablet
01 3APO-ALPRAZ
02 1APO-ALPRAZ TS
03 3NAT-ALPRAZOLAM
04 3PRO-ALPRAZOLAM
05 2TEVA-ALPRAZOLAM
06 3XANAX
07 1XANAX TS
08 4Blank
Regulatory Info : Generic
Registration Country : Canada
Brand Name :
Dosage Form : TABLET
Dosage Strength : 0.25MG
Packaging :
Approval Date :
Application Number : 74085
Regulatory Info : Generic
Registration Country : Canada
Regulatory Info : Generic
Registration Country : Canada
Brand Name :
Dosage Form : TABLET
Dosage Strength : 0.5MG
Packaging :
Approval Date :
Application Number : 78056
Regulatory Info : Generic
Registration Country : Canada
Regulatory Info : Generic
Registration Country : Canada
Brand Name :
Dosage Form : TABLET
Dosage Strength : 1MG
Packaging :
Approval Date :
Application Number : 74294
Regulatory Info : Generic
Registration Country : Canada
Regulatory Info : Generic
Registration Country : Canada
Brand Name :
Dosage Form : TABLET
Dosage Strength : 2MG
Packaging :
Approval Date :
Application Number : 74085
Regulatory Info : Generic
Registration Country : Canada
Regulatory Info : Targeted (CDSA IV)
Registration Country : Canada
Brand Name : APO-ALPRAZ
Dosage Form : TABLET
Dosage Strength : 0.25MG
Packaging : 100/1000
Approval Date :
Application Number : 865397
Regulatory Info : Targeted (CDSA IV)
Registration Country : Canada
Regulatory Info : Targeted (CDSA IV)
Registration Country : Canada
Brand Name : XANAX
Dosage Form : TABLET
Dosage Strength : 1MG
Packaging :
Approval Date :
Application Number : 723770
Regulatory Info : Targeted (CDSA IV)
Registration Country : Canada
Regulatory Info : Targeted (CDSA IV)
Registration Country : Canada
Brand Name : XANAX TS
Dosage Form : TABLET
Dosage Strength : 2MG
Packaging :
Approval Date :
Application Number : 813958
Regulatory Info : Targeted (CDSA IV)
Registration Country : Canada
Regulatory Info : Targeted (CDSA IV)
Registration Country : Canada
Brand Name : NAT-ALPRAZOLAM
Dosage Form : Tablet
Dosage Strength : 0.25MG
Packaging : 100/500/1000
Approval Date :
Application Number :
Regulatory Info : Targeted (CDSA IV)
Registration Country : Canada
Regulatory Info : Targeted (CDSA IV)
Registration Country : Canada
Brand Name : NAT-ALPRAZOLAM
Dosage Form : Tablet
Dosage Strength : 0.5MG
Packaging : 100/500/1000
Approval Date :
Application Number :
Regulatory Info : Targeted (CDSA IV)
Registration Country : Canada
Regulatory Info : Targeted (CDSA IV)
Registration Country : Canada
Brand Name : NAT-ALPRAZOLAM
Dosage Form : Tablet
Dosage Strength : 1MG
Packaging : 100/500/1000
Approval Date :
Application Number :
Regulatory Info : Targeted (CDSA IV)
Registration Country : Canada
LOOKING FOR A SUPPLIER?